TickerFactsScreenerDevelopers

RIGEL PHARMACEUTICALS INC (RIGL) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2018: $287.0K2019: $906.0K2020: $895.0K2021: $1.08M2022: $1.75M2023: $7.11M2024: $18.65M2025: $19.62M$19.62M
2018Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$19.62M+5.2%
2024$18.65M+162.3%
2023$7.11M+306.5%
2022$1.75M+61.5%
2021$1.08M+21.0%
2020$895.0K-1.2%
2019$906.0K+215.7%
2018$287.0K—